Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study

Cristina Gavina1, Francisco Araújo2, Carla Teixeira3

  • 1Pedro Hispano Hospital - ULS Matosinhos, Matosinhos, Portugal; Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal; UnIC, Faculty of Medicine, University of Porto, Porto, Portugal.

Atherosclerosis
|June 11, 2023
PubMed

Insights

Women are 22% less likely to achieve their low-density lipoprotein cholesterol (LDL-C) goals compared to men, even after adjusting for various health factors. This highlights a significant sex disparity in lipid-lowering therapy (LLT) effectiveness.

Area of Science:

  • Cardiology
  • Pharmacotherapy
  • Health Disparities

Background:

  • Cardiovascular diseases exhibit distinct clinical presentations and treatment responses between sexes.
  • Sex disparities in achieving lipid-lowering therapy (LLT) goals necessitate focused assessment and further research.
  • Understanding these differences is crucial for optimizing treatment strategies and improving patient outcomes.

Purpose of the Study:

  • To investigate the influence of sex on the achievement of low-density lipoprotein cholesterol (LDL-C) goals.
  • To analyze the role of sex in lipid management, accounting for age, cardiovascular risk, LLT intensity, mental health, and social deprivation.
  • To provide evidence for tailoring LLT strategies to address sex-specific needs.

Main Methods:

  • Retrospective cohort analysis of electronic health records from 30,323 patients in Portugal (2012-2020).
  • Episode-based design focusing on LLT initiation or intensity changes.
  • Multivariate Cox regression modeling to assess the likelihood of reaching LDL-C goals at 180 days, with follow-up to 360 days, stratified by cardiovascular risk.

Main Results:

  • Analysis included 40,032 LLT exposure episodes.
  • Male sex, older age, lower CV risk, and higher LLT intensity were associated with better LDL-C control.
  • Women were 22% less likely to achieve LDL-C goals than men (HR=0.78), independent of covariates.

Conclusions:

  • Women demonstrate a reduced likelihood of achieving LDL-C goals compared to men, even after adjusting for key clinical and demographic factors.
  • These findings emphasize the need for further research into sex-specific factors influencing LLT.
  • Tailoring LLT management strategies for women is essential to mitigate observed disparities.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
606
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
713
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
205
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33